CTO: Length’s Impact on Success

The rise of chronic total occlusions (CTO) percutaneous coronary interventions (PCI) goes hand in hand with technological development, through still posing a great challenge, one not exactly exempt from complications. 

CTO: la longitud impacta en el éxito

An important criterion to successful CTO PCI is length: ≥20 mm lesions lower the odds, according to J-CTO Score. However, increasing operator experience and the development of new guidewires and micro-catheters is gradually changing the situation.

The study looked at 10335 CTO PCI performed between 2012 and 2022. 7208 of these interventions were ≥20 mm long (69.7%) and 3127 <20 mm long (30.3%).

Mean age was similar in both groups, but those with ≥20 mm occlusions were more often men, smokers, presenting hypertension, dyslipidemia, diabetes, peripheral vascular disease, cardiac failure, lower ejection fraction, MI, and CABG. 

The artery that more frequently presented CTO was the right coronary (57.3%), followed by the anterior descending (23.4%) and the circumflex.

Read also: ISAR Score: Can We Predict the Need for Repeat PCI in DES Restenosis?

≥20 mm occlusions presented more unfavorable angiographic characteristics, more tortuosity, and severe calcification. Also, the dissection and reentry technique was more often used in the group, as well as the retrograde strategy.

Crossing success rate was lower in patients presenting longer lesions, who also needed more stents, longer fluoroscopy time and longer procedures. 

≥20 mm lesions were associated to lower technical and procedural success (84.4% vs. 91.8%; p < 0.001 and 81.9% vs. 90.3%; p < 0.001 respectively). In hospital MACE was higher in this group (3.4% vs. 1.9%; p < 0.001), as was AMI (0.7% vs. 0.26%; p = 0.009), perforations (5.15% vs. 3.87%; p = 0.007) and the presence of thrombi and dissection (0.84% vs. 0.35%; p = 0.008).

Read also: Percutaneous Access Closure in TAVR: Are Devices Similar?

A 10 mm increase in occlusion length was associated to lower technical success rate. 

After multivariable analysis, (shorter) lesion length was associated to reduced MACE and technical success. 

Conclusion

CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS‐CTO registry.

Reference: Athanasios Rempakos, et al. Catheter Cardiovasc Interv. 2023;101:747–755.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...